Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Cancers
|
September 10, 2021
Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment
Su Jung Oh-Hohenhorst, Tobias Lange
International Journal of Molecular Sciences
|
May 27, 2023
Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors
Pierre Tennstedt, Su Jung Oh-Hohenhorst
Endocrine-Related Cancer
|
March 3, 2012
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
Su Jung Oh, Holger H H Erb, Alfred Hobisch, et al.
The American Journal of Pathology
|
October 9, 2012
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205
Martin Puhr, Julia Hoefer, Georg Schäfer, et al.
International Journal of Oncology
|
April 3, 2020
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth
Joong Sun Kim, Soo Kyung Jeong, Su Jung Oh, et al.
Urology
|
November 10, 2019
Rectal Swabs for Detecting Multidrug Resistant Bacteria Prior to Transrectal Prostate Fusion Biopsy: A Prospective Evaluation of Risk Factor Screening and Microbiologic Findings
Christoph Würnschimmel, Luis Busto Martin, Sami-Ramzi Leyh-Bannurah, et al.
Frontiers in Surgery
|
January 13, 2018
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy
Su Jung Oh, Philipp Mandel, Felix K H Chun, et al.
Food Science and Biotechnology
|
April 25, 2022
Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation
Wol Soon Jo, Sung Dae Kim, Soo Kyung Jeong, et al.
World Journal of Urology
|
April 6, 2020
Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer
Sami-Ramzi Leyh-Bannurah, Mykyta Kachanov, Pierre I Karakiewicz, et al.
International Immunopharmacology
|
July 22, 2014
Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages
Soo Kyung Jeong, Kwangmo Yang, You Soo Park, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Cancers
|
September 10, 2021
Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment
Su Jung Oh-Hohenhorst, Tobias Lange
International Journal of Molecular Sciences
|
May 27, 2023
Advances, Limitations and Future Challenges in the Management of Immunotherapy for Hematological Diseases and Solid Tumors
Pierre Tennstedt, Su Jung Oh-Hohenhorst
Endocrine-Related Cancer
|
March 3, 2012
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
Su Jung Oh, Holger H H Erb, Alfred Hobisch, et al.
The American Journal of Pathology
|
October 9, 2012
Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205
Martin Puhr, Julia Hoefer, Georg Schäfer, et al.
International Journal of Oncology
|
April 3, 2020
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth
Joong Sun Kim, Soo Kyung Jeong, Su Jung Oh, et al.
Urology
|
November 10, 2019
Rectal Swabs for Detecting Multidrug Resistant Bacteria Prior to Transrectal Prostate Fusion Biopsy: A Prospective Evaluation of Risk Factor Screening and Microbiologic Findings
Christoph Würnschimmel, Luis Busto Martin, Sami-Ramzi Leyh-Bannurah, et al.
Frontiers in Surgery
|
January 13, 2018
AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy
Su Jung Oh, Philipp Mandel, Felix K H Chun, et al.
Food Science and Biotechnology
|
April 25, 2022
Resveratrol analogue, HS-1793, inhibits inflammatory mediator release from macrophages by interfering with the TLR4 mediated NF-κB activation
Wol Soon Jo, Sung Dae Kim, Soo Kyung Jeong, et al.
World Journal of Urology
|
April 6, 2020
Combined systematic versus stand-alone multiparametric MRI-guided targeted fusion biopsy: nomogram prediction of non-organ-confined prostate cancer
Sami-Ramzi Leyh-Bannurah, Mykyta Kachanov, Pierre I Karakiewicz, et al.
International Immunopharmacology
|
July 22, 2014
Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages
Soo Kyung Jeong, Kwangmo Yang, You Soo Park, et al.
Page
of 4